· 方法论
一个帅哥就算和 Clavicular 并排也更抢眼，但这不会影响任何基本面。 我上个月也像 Leopold 一样，削减了一些 $LITE、$COHR 敞口。 但我把它轮动到一个具体光学主题：$SIVE / Foci 这样的 CPO 名字。 整个光子学供应链正处于巨大超级周期的起点，而做多 CPO 作为架构范式转变，没有什么比这更有吸引力。 市场把两家公司等同于整个主题，然后一起卖掉所有相关东西。 不过对理解细节的人来说，这是很好的买入机会。 我仍认为 Lumentum 和 $COHR 有上行，只是如果只买股票，在当前价格下不太可能像其他名字那样快速翻倍。
A good looking guy that would mog Clavicular side by side has no impact to any fundamentals. I cut some exposure too in $LITE $COHR like Leopold, last month. But rotated it to a specific optical theme with CPO names like $SIVE / Foci. The entire photonics supply chain is in the start of a massive supercycle and there’s nothing more compelling going long on CPO as an architectural paradigm shift. Markets conflate two companies as the entire theme and sell off anything with it. Great buying opportunity for people who understands the nuance though. I still think there’s upside for Lumentum and $COHR, just less likely to double at current prices as fast if you’re going shares only.